MX2017015664A - Administracion intravenosa de citrulina durante cirugia. - Google Patents

Administracion intravenosa de citrulina durante cirugia.

Info

Publication number
MX2017015664A
MX2017015664A MX2017015664A MX2017015664A MX2017015664A MX 2017015664 A MX2017015664 A MX 2017015664A MX 2017015664 A MX2017015664 A MX 2017015664A MX 2017015664 A MX2017015664 A MX 2017015664A MX 2017015664 A MX2017015664 A MX 2017015664A
Authority
MX
Mexico
Prior art keywords
during surgery
intravenous administration
citrulline
citrulline during
surgery
Prior art date
Application number
MX2017015664A
Other languages
English (en)
Inventor
Summar Marshall
Barr Frederick
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57601710&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017015664(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of MX2017015664A publication Critical patent/MX2017015664A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3666Cardiac or cardiopulmonary bypass, e.g. heart-lung machines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un método para administrar citrulina a un paciente durante la cirugía sin filtración de la hemólisis.
MX2017015664A 2015-06-29 2016-06-29 Administracion intravenosa de citrulina durante cirugia. MX2017015664A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562186085P 2015-06-29 2015-06-29
PCT/US2016/040138 WO2017004233A1 (en) 2015-06-29 2016-06-29 Intravenous administration of citrulline during surgery

Publications (1)

Publication Number Publication Date
MX2017015664A true MX2017015664A (es) 2018-04-18

Family

ID=57601710

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017015664A MX2017015664A (es) 2015-06-29 2016-06-29 Administracion intravenosa de citrulina durante cirugia.

Country Status (13)

Country Link
US (1) US10525026B2 (es)
EP (1) EP3313390A4 (es)
JP (1) JP6876632B2 (es)
KR (1) KR102320547B1 (es)
AU (1) AU2016286115B9 (es)
BR (1) BR112017025768A2 (es)
CA (1) CA2990279C (es)
CO (1) CO2018000768A2 (es)
HK (1) HK1254855A1 (es)
IL (1) IL256608A (es)
MX (1) MX2017015664A (es)
RU (1) RU2733738C2 (es)
WO (1) WO2017004233A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10144706B2 (en) * 2016-09-01 2018-12-04 Bristol-Myers Squibb Company Compounds useful as immunomodulators
US10265286B2 (en) 2016-12-28 2019-04-23 Vanderbilt University Sequelae of cardiopulmonary bypass-induced pulmonary injury
AR111082A1 (es) * 2017-02-27 2019-05-29 Univ Vanderbilt Citrulina para el tratamiento de la crisis de células falciformes
US12064409B2 (en) 2021-06-22 2024-08-20 Vanderbilt University Action of L-citrulline to prevent or treat endothelial dysfunction
US20230404956A1 (en) * 2022-06-21 2023-12-21 Asklepion Pharmaceuticals Llc Therapeutic window for citrulline therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346382B1 (en) 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
US9486429B2 (en) 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
WO2007114903A2 (en) * 2006-04-04 2007-10-11 Nestec S.A. Treatments using citrulline
CN101083589B (zh) 2007-07-13 2010-08-11 华为技术有限公司 无源光网络中的终端检测认证方法、装置及操作管理系统
CN201069480Y (zh) 2007-07-16 2008-06-04 何凎 透雾摄像机镜头
DK2247297T3 (en) 2008-01-31 2019-03-11 Univ Vanderbilt THERAPEUTIC TREATMENT OF LUNG CONDITIONS
JP5623916B2 (ja) 2008-01-31 2014-11-12 バンダービルト・ユニバーシティVanderbilt University 動脈瘤性くも膜下出血及び血管痙攣に対する医薬組成物

Also Published As

Publication number Publication date
EP3313390A4 (en) 2019-02-20
JP2018519301A (ja) 2018-07-19
RU2733738C2 (ru) 2020-10-06
AU2016286115B9 (en) 2021-02-04
BR112017025768A2 (pt) 2018-08-14
KR102320547B1 (ko) 2021-11-01
HK1254855A1 (zh) 2019-07-26
KR20180021803A (ko) 2018-03-05
AU2016286115A1 (en) 2018-02-15
IL256608A (en) 2018-02-28
RU2018103072A (ru) 2019-07-30
US10525026B2 (en) 2020-01-07
JP6876632B2 (ja) 2021-05-26
CO2018000768A2 (es) 2018-07-10
EP3313390A1 (en) 2018-05-02
AU2016286115B2 (en) 2021-01-21
CA2990279A1 (en) 2017-01-05
RU2018103072A3 (es) 2019-12-25
WO2017004233A1 (en) 2017-01-05
US20160374972A1 (en) 2016-12-29
CA2990279C (en) 2022-07-05

Similar Documents

Publication Publication Date Title
MX2017015664A (es) Administracion intravenosa de citrulina durante cirugia.
CA3011103A1 (en) Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
MX2018004328A (es) Composiciones farmaceuticas estabilizantes de camptotecina.
PH12016502352A1 (en) Pharmaceutical composition
EP3275482A4 (en) Syringe holder and medical solution administration set
TW201613578A (en) Pharmaceutical combinations
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
SA517390475B1 (ar) نظام أكياس متعددة وطريقة لتحضير مكونات الدم
IL270715A (en) Cannula for intravascular blood pump
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EP3305347A4 (en) LIQUID INFUSION DEVICE FOR MEDICINE ADMINISTRATION TO A PATIENT
EP3893965A4 (en) KINDLESS INFUSION SET FOR MEDICAL USE
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
GB201807475D0 (en) Protein nanostructure based drug delivery system for the delivery of therapeutic agents to the anterior segment of the eye
MX2019005670A (es) Secuelas de lesion pulmonar inducida por baipas cardiopulmonar.
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
PH12016501347A1 (en) Filters for infusion sets
SG10201809418VA (en) New administration routes of insulin, insulin analogs or derivatives of insulin
UA99921U (ru) Способ контролируемой седации у пациентов с состоянием отмены алкоголя в отделении интенсивной терапии
UA96488U (uk) Спосіб лікування порушень гемоваскулярного гемостазу у хворих на ішемічну хворобу серця
UA77018U (ru) Способ лечения больных тромбозом сосудов сетчатки
UA100411U (ru) Способ химической ваготомии
UA82406U (ru) Способ стабилизации гемодинамики при высокой спинальной анестезии в абдоминальной хирургии
UA91788U (uk) Спосіб інтра- та післяопераційного введення гепатопротекторів при вогнищевих ураженнях печінки
UA92326U (ru) Способ коррекции системы антиоксидантной защиты у больных вегетативной дистонией с артериальной гипертензией